Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [3422]

Effects of panitumumab against oesophageal-gastro cancer and carcinomas

Dr Tom Waddell – Royal Marsden Hospital, Sutton, UK

Effects of panitumumab against oesophageal-gastro cancer and carcinomas ( Dr Tom Waddell – Royal Marsden Hospital, Sutton, UK )

Effects of lapatinib and trastuzumab on progression free survival

Dr Nancy Lin – Dana Farber Cancer Institute, Boston, MA, USA

Effects of lapatinib and trastuzumab on progression free survival ( Dr Nancy Lin – Dana Farber Cancer Institute, Boston, MA, USA )

ASCO 2012: Advances in lymphoma; bendamustine combination in indolent lymphoma

Prof John Gribben - Barts & The London Trust Cancer Centre, UK; Prof Mathias...

ASCO 2012: Advances in lymphoma; bendamustine combination in indolent lymphoma ( Prof John Gribben - Barts & The London Trust Cancer Centre, UK; Prof Mathias Rummel - University Hospital Giessen, Germany )

President's overview of ASCO 2012

Dr Michael Link - Stanford School of Medicine, California, USA

President's overview of ASCO 2012 ( Dr Michael Link - Stanford School of Medicine, California, USA )

Drug shortage impact on cancer care and efforts to resolve the issue

Dr Sandra Kweder - US Food and Drug Administration

Drug shortage impact on cancer care and efforts to resolve the issue ( Dr Sandra Kweder - US Food and Drug Administration )

New BRAF inhibitor dabrafenib delays disease progression in advanced melanoma

Dr Axel Hauschild - Universitaetsklinikum Schleswig-Holstein, Germany

New BRAF inhibitor dabrafenib delays disease progression in advanced melanoma ( Dr Axel Hauschild - Universitaetsklinikum Schleswig-Holstein, Germany )

Increased risk of breast cancer among young women treated with radiation as a...

Dr Chaya Moskowitz - Memorial Sloan-Kettering Cancer Center, New York, USA

Increased risk of breast cancer among young women treated with radiation as a child ( Dr Chaya Moskowitz - Memorial Sloan-Kettering Cancer Center, New York, USA )

New MEK inhibitor, trametinib, improves survival in advanced melanoma

Dr Caroline Robert - Institut Gustave Roussy, Villejuif, France

New MEK inhibitor, trametinib, improves survival in advanced melanoma ( Dr Caroline Robert - Institut Gustave Roussy, Villejuif, France )

First effective treatment for chemotherapy-induced peripheral neuropathy

Dr Ellen Lavoie Smith - University of Michigan, Ann Arbor, USA

First effective treatment for chemotherapy-induced peripheral neuropathy ( Dr Ellen Lavoie Smith - University of Michigan, Ann Arbor, USA )

Afatinib delays progression of advanced lung adenocarcinomas

Dr James Yang - National Taiwan University Hospital, Taipei

Afatinib delays progression of advanced lung adenocarcinomas ( Dr James Yang - National Taiwan University Hospital, Taipei )

Costly drugs versus paclitaxel as first line therapy for locally advanced or...

Dr Hope Rugo - University of California San Francisco, USA

Costly drugs versus paclitaxel as first line therapy for locally advanced or metastatic breast cancer ( Dr Hope Rugo - University of California San Francisco, USA )

Regorafenib effective for GISTs that progress due to resistance to approved...

Dr George Demetri - Dana Farber Cancer Institute, Boston, USA

Regorafenib effective for GISTs that progress due to resistance to approved targeted therapies ( Dr George Demetri - Dana Farber Cancer Institute, Boston, USA )

More from ecancer